Search results for 15

Tetratricopeptide Repeat Protein 15 (TTC15) Antibody, Abbexa, abx027382

TTC15 contains 4 TPR repeats.

15 Lipoxygenase 1/ALOX15 Antibody (YA1091), MedChemexpress, HY-P81346

15 Lipoxygenase 1/ALOX15 Antibody (YA1091) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to 15 Lipoxygenase 1/ALOX15 .

15 Lipoxygenase 1/ALOX15 Atibody (YA1309), MedChemexpress, HY-P81564

15 Lipoxygenase 1/ALOX15 Antibody (YA1309) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to 15 Lipoxygenase 1/ALOX15.

Anti-Calpain 15/SOLH antibody [EPR11078], Abcam, AB170926

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Human Protocadherin 15 (PCDH15) ELISA Kit, Abbexa, abx152866

Human Protocadherin 15 (PCDH15) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human Protocadherin 15 (PCDH15) concentrations in tissue homogenates, cell lysates and other biological fluids. This assay has high sensitivity and excellent specificity for detection of Protocadherin 15 (PCDH15)No significant cross-reactivity or interference between Protocadherin 15 (PCDH15) and analogues was observed.

APC Anti-CCR2 antibody [EPR20844-15], Abcam, AB314258

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

APC Anti-CD13 antibody [WM-15], Abcam, AB95545

APC Anti-CD14 antibody [MEM-15], Abcam, AB60901

Avoid prolonged exposure to light. Short-term exposure to room temperature should not affect the quality of the reagent.The purified antibody is conjugated with cross-linked Allophycocyanin (APC) under optimum conditions.

APC Anti-CX3CR1 antibody [EPR22354-15], Abcam, AB314257

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

APC Anti-Cytokeratin 15 antibody [EPR1614Y], Abcam, AB305711

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .